Anika Therapeutics (Cingal) | About the Brand



Currently headquartered at Bedford, MA Anika Therapeutics was founded back in 1992 as a spinoff of MedChem Products, Inc. Just three years later in 1996, they received their CE Mark approval for their Orthovisc product, a solution geared towards treatment of osteoarthritis symptoms, and eight years later the same product received its FDA approval in the USA. Ever since their creation in almost 30 years ago, the company has developed and manufactured multiple minimally invasive products that aim to provide comfort and relief to patients in orthopedic care. 

Their products are mostly based on hyaluronic acid, the naturally occurring substance in the body which has a similar viscosity to synovial fluid, the liquid that keeps the bones from rubbing against each other in the synovial joints. Their latest generation product, Cingal received the CE Mark in 2016, and has also received Health Canada approval in 2015. As of 2020, the company has 277 employees, and has an annual revenue of over $144 million.  


Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.